Mining of Respiratory System Toxicity Risk Signals for Fulvestrant Based on the Tianjin Adverse Reaction Monitoring Center and the FDA Adverse Event Reporting System Database

Key Points

• Respiratory adverse events signal a notable risk associated with fulvestrant use, necessitating vigilant observation.
• Data indicates significant respiratory toxicity reports, highlighting the need for comprehensive monitoring protocols.
• Analysis of adverse event reports from Tianjin and FDA databases underscores the potential hazards during treatment.
• Increased awareness and monitoring may prevent serious respiratory complications associated with fulvestrant therapy.